IRIS
D'ANNA, Rosario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.322
NA - Nord America 6.211
AS - Asia 3.445
SA - Sud America 1.402
AF - Africa 102
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 2
Totale 17.496
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.092
RU - Federazione Russa 2.046
SG - Singapore 1.485
BR - Brasile 1.232
CN - Cina 1.042
IE - Irlanda 1.029
SE - Svezia 1.027
IT - Italia 614
HK - Hong Kong 409
DE - Germania 407
UA - Ucraina 312
PL - Polonia 208
FI - Finlandia 206
VN - Vietnam 180
GB - Regno Unito 165
FR - Francia 138
IN - India 82
AR - Argentina 61
CA - Canada 56
BE - Belgio 42
MX - Messico 41
ZA - Sudafrica 35
BD - Bangladesh 30
EC - Ecuador 30
JP - Giappone 30
NL - Olanda 29
TR - Turchia 25
IQ - Iraq 23
AT - Austria 21
ID - Indonesia 18
MA - Marocco 18
IR - Iran 17
UZ - Uzbekistan 17
VE - Venezuela 16
CZ - Repubblica Ceca 15
ES - Italia 15
CO - Colombia 13
EG - Egitto 13
UY - Uruguay 13
AL - Albania 10
AU - Australia 10
PE - Perù 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 8
KE - Kenya 8
PK - Pakistan 8
TN - Tunisia 8
KZ - Kazakistan 7
LT - Lituania 7
BO - Bolivia 6
CI - Costa d'Avorio 6
CL - Cile 6
JO - Giordania 6
KR - Corea 6
DO - Repubblica Dominicana 5
GY - Guiana 5
JM - Giamaica 5
KH - Cambogia 5
OM - Oman 5
RO - Romania 5
AM - Armenia 4
LB - Libano 4
LU - Lussemburgo 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CH - Svizzera 3
DZ - Algeria 3
GR - Grecia 3
HN - Honduras 3
IL - Israele 3
NP - Nepal 3
RS - Serbia 3
SA - Arabia Saudita 3
SN - Senegal 3
BN - Brunei Darussalam 2
BY - Bielorussia 2
ET - Etiopia 2
LV - Lettonia 2
MN - Mongolia 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 17.487
Salva come PNG Salva come JPEG
Città #
Moscow 1.031
Dublin 1.029
Ashburn 831
Singapore 799
Chandler 736
Dallas 676
Jacksonville 644
Nyköping 513
Beijing 458
Hong Kong 408
Warsaw 197
Messina 187
Princeton 170
Boardman 162
Cambridge 157
Los Angeles 155
Medford 153
Dearborn 144
Ann Arbor 139
The Dalles 131
Des Moines 127
Munich 101
São Paulo 99
Buffalo 80
New York 69
Ho Chi Minh City 65
Jinan 57
Woodbridge 53
Wilmington 44
Redondo Beach 42
Shenyang 40
Brussels 39
Hanoi 38
Belo Horizonte 36
Frankfurt am Main 36
Turku 35
Catania 34
Tianjin 34
San Mateo 33
Bremen 30
Zhengzhou 30
Rio de Janeiro 29
Hyderabad 28
Lancaster 28
Düsseldorf 26
Hebei 26
Brooklyn 25
Houston 24
Porto Alegre 24
Santa Clara 24
Tokyo 24
Curitiba 23
Helsinki 23
London 23
Seattle 23
Brasília 21
Guangzhou 21
Montreal 21
Ningbo 21
Johannesburg 19
Nanjing 19
Stockholm 19
Rome 18
Chennai 17
Denver 17
Haikou 17
Taizhou 17
Boston 16
Lauterbourg 16
Pune 16
Atlanta 15
Sorocaba 15
Dong Ket 14
Orem 14
Tashkent 14
Ottawa 13
Washington 13
Campinas 12
Council Bluffs 12
Fortaleza 12
Quito 12
Campo Grande 11
Guarulhos 11
Hefei 11
Lanzhou 11
Norwalk 11
Baghdad 10
Columbus 10
Goiânia 10
Guayaquil 10
Jakarta 10
Montevideo 10
Nanchang 10
Poplar 10
Recife 10
San Francisco 10
Santo André 10
Viagrande 10
Vienna 10
Betim 9
Totale 10.807
Salva come PNG Salva come JPEG
Nome #
Inositolo e sindrome metabolica in menopausa 256
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 190
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 185
Coffee intake during pregnancy and neonatal low birth weight: data from a multicenter Italian cross sectional study 185
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 179
Antiviral activity of Ellagic acid and Annona Muricata in cervical HPV related pre-neoplastic lesions: A randomized trial 177
Adiponectin and insulin resistance in early- and late-onset pre-eclampsia 173
Italian risk factor-based screening for gestational diabetes. 165
Bone remodeling and regulation of sRANKL/OPG balance after genistein administration in osteopenic, postmenopausal women 164
ADAM 12 and PAPP-A at 14–17 weeks' gestation as biomarkers of pre-eclampsia. 163
Abnormal glucose tolerance later in life in women affected by glucose intolerance during pregnancy 159
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 156
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 155
Effects of myo-inositol on glucose variability in women with gestational diabetes 153
A single abnormal value of the glucose tolerance test is related to increased adverse perinatal outcome. 152
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 152
Myo-inositol may prevent gestational diabetes in PCOS women 149
Myo-inositol and melatonin in the menopausal transition 149
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 147
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 145
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 144
A New Supplement for the Treatment of Metabolic Syndrome in Postmenopausal Women 143
B cell leukaemia/lymphoma-2 protein concentrations during normal pregnancy 141
Cardiac diastolic evaluation in pregnant women with abnormal glucose tolerance: an opportunity to detect the early and subclinical alterations and prevent cardiovascular diseases 139
Vigilance on use of drugs, herbal products, and food supplements during pregnancy: focus on fosfomycin 139
Peroxisome proliferator-activated receptor modulation during metabolic diseases and cancers: master and minions 137
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 136
Cardiovascular effects of the phytoestrogen genistein 135
Decreased endothelial progenitor cells (EPCs) and increased Natural Killer (NK) cells in peripheral blood as possible early markers of preeclampsia: a case-control analysis 134
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 133
Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction 131
C-reactive protein as an early predictor of gestational diabetes mellitus 131
First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. 131
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 130
Cardiovascular effects of raloxifene hydrochloride 129
ADAM 12 come marker precoce di preeclampsia 129
Compliance with hormone replacement therapy in postmenopausal Sicilian women 128
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 127
Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension 127
Effects of a new vaginal cream containing visnadine, prenylflavonoids and bovine colostrum on Vaginal Health Index Score and Female Sexual Function Index in post-menopausal sexually active women affected by vaginal dryness: A pilot study 127
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 126
Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis 126
Association of maternal food insecurity before and during pregnancy with fetal structural anomalies: A multicenter case-control study protocol 126
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 125
GENISTEIN AGLYCONE DOES NOT AFFECT THYROID FUNCTION: RESULTS FROM A THREE-YEAR, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL 125
First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes 124
ICAM-1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR 123
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 123
Dietary management of skin health: The role of genistein 123
Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders 121
Maternal serum PAPP-A as an early marker of obstetric complications? 121
Closed vs. Open Oocyte Vitrification Methods Are Equally Effective for Blastocyst Embryo Transfers: Prospective Study from a Sibling Oocyte Donation Program 121
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 120
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 120
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes–a randomized and open-label, placebo-controlled clinical trial 120
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 120
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 119
SICUREZZA ED EFFICACIA DELLA GENISTEINA IN DONNE OSTEOPENICHE IN POSTMENOPAUSA 118
Midtrimester amniotic fluid adiponectin in normal pregnancy. 117
Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women 117
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome 116
Differenze socio.demografiche e psicologiche tra gruppi di pazienti in peri e post menopausa 115
Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance 115
Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy 112
Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. 112
Effetti del fitoestrogeno genisteina su donne in post-menopausa affette da sindrome metabolica 112
Improvement of selective screening strategy for gestational diabetes through a more accuratedefinition of high-risk groups 112
Myo-inositol supplementation and the onset of gestational diabetes mellitus in pregnant women with a family hystory of type 2 diabetes. A prospective, randomized, placebo controlled study 111
Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study 111
Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction? 110
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 110
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 110
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 109
The phytoestrogen alpha-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats 108
La disfunzione diastolica nel diabete gestazionale 106
CORRESPONDENCE BETWEEN FIRST TRIMESTER FASTING GLICEMIA AND ORAL GLUCOSE TOLERANCE TEST IN GESTATIONAL DIABETES DIAGNOSIS 106
Midtrimester Amniotic Fluid Leptin and Insulin Levels and Subsequent Gestational Diabetes. 105
Myo-inositol in Down syndrome amniotic fluid. A case-control study. 104
First- and Second-Trimester ADAM12s in Down Syndrome Screening. 103
Prevalence of risk factors in the screening of carbohydrate intolerance in pregnancy 102
Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women. 102
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 100
Prevalenza dei fattori di rischio associati al diabete gestazionale e alla ridotta tolleranza glucidica in gravidanza 100
Second trimester neutrophil gelatinase-associated lipocalin as a potential prediagnostic marker of preeclampsia. 100
Effects of a New Flavonoid and Myo-Inositol Supplement on Some Biomarkers of Cardiovascular Risk in Postmenopausal Women: A Randomized Trial 100
Anti-SARS-CoV2 IgG are present in the amniotic fluid of both infected and vaccinated women at second trimester of pregnancy: a cohort study 99
The clinical utility of serum uric acid measurements in pre- eclampsia and transient hypertension in pregnancy 99
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 99
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review 98
Effects of genistein aglycone on endometrial hyperplasia in premenopausal women: a randomized controlled trial 97
Genistein aglycone use in metabolic syndrome: preliminary results from a randomized clinical trial in postmenopausal women 96
Pregnancy outcome following mid-trimester amniocentesis 95
The impact of kidney development on the life course: a consensus document for action 94
Myoinositol plus α‑lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study 93
Inflammatory markers in women with a recent history of gestational diabetes mellitus 91
A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group 91
Interleukin 31 is involved in intrahepatic cholestasis of pregnancy 91
Endothelin-1 production in umbilical arteries from hypertensive pregnant women 90
Livelli serici di OPG e RANKL in donne osteopeniche in post-menopausa, trattate per 2 anni col fitoestrogeno genisteina 90
THE PHYTOESTROGEN GENISTEIN PHYSIOLOGICALLY IMPROVES BONE AND CARDIOVASCULAR FUNCTIONALITY IN POSTMENOPAUSAL WOMEN 90
Totale 12.564
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.525
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.525
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021682 0 0 0 0 0 120 90 128 73 138 79 54
2021/20221.216 11 145 29 44 47 15 70 44 35 282 148 346
2022/20233.036 223 283 149 185 252 300 33 177 1.289 16 96 33
2023/2024770 60 108 43 106 62 111 27 30 0 58 21 144
2024/20253.387 68 29 70 221 147 132 54 717 850 238 325 536
2025/20265.777 595 724 733 759 811 2.155 0 0 0 0 0 0
Totale 17.764